Brain, Vol. 125, No. 6, 1358-1365,
June 2002
© 2002 Guarantors of Brain
Striatal and extrastriatal dysfunction in Parkinsons disease with dementia: a 6-[18F]fluoro-L-dopa PET study
1 Department of Biofunctional Research, National Institute for Longevity Sciences and 2 Department of Neurology, Chubu National Hospital, Obu, Japan, 3 MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London and 4 Institute of Neurology, Queen Square, London, UK
Correspondence to: Dr Kengo Ito, Department of Biofunctional Research, National Institute for Longevity Sciences, 36-3 Gengo, Morioka-cho, Obu, Aichi Prefecture, 474-8522, Japan E-mail: kito{at}nils.go.jp
We investigated the relative differences in dopaminergic function through the whole brain in patients with Parkinsons disease without dementia (PD) and with dementia (PDD) using 6-[18F]fluoro-L-dopa (18F-dopa) PET and a voxel-by-voxel analysis. The 10 PD and 10 PDD patients were equivalently disabled, having mean scores of 3.2 ± 0.6 and 3.2 ± 0.7, respectively, on the Hoehn and Yahr rating scale. 18F-dopa influx constant (Ki) images of those patients and 15 normal age-matched subjects were transformed into standard stereotactic space. The significant differences between the groups (expressed in mean regional Ki values) were localized with statistical parametric mapping (SPM) on a voxel-by-voxel basis. Compared with the normal group, SPM localized declines of the 18F-dopa Ki bilaterally in the putamen, the right caudate nucleus and the left ventral midbrain for the PD group (P < 0.01, corrected). Com pared with the normal group, the PDD group showed reduced 18F-dopa Ki bilaterally in the striatum, midbrain and anterior cingulate area (P < 0.01, corrected). A relative difference in 18F-dopa uptake between PD and PDD was the bilateral decline in the anterior cingulate area and ventral striatum and in the right caudate nucleus in the PDD group (P < 0.001, corrected). Accordingly, we conclude that dementia in PD is associated with impaired mesolimbic and caudate dopaminergic function.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. H. Schott, L. Niehaus, B. C. Wittmann, H. Schutze, C. I. Seidenbecher, H.-J. Heinze, and E. Duzel Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing Brain, September 1, 2007; 130(9): 2412 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J G Lewis, T Foltynie, A D Blackwell, T W Robbins, A M Owen, and R A Barker Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 343 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nagano-Saito, Y. Washimi, Y. Arahata, T. Kachi, J. P. Lerch, A. C. Evans, A. Dagher, and K. Ito Cerebral atrophy and its relation to cognitive impairment in Parkinson disease Neurology, January 25, 2005; 64(2): 224 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Owen Cognitive Dysfunction in Parkinson's Disease: The Role of Frontostriatal Circuitry Neuroscientist, December 1, 2004; 10(6): 525 - 537. [Abstract] [PDF] |
||||
![]() |
N Mabuchi, H Watanabe, N Atsuta, M Hirayama, H Ito, H Fukatsu, T Kato, K Ito, and G Sobue Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1768 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Whone, D. L. Bailey, P. Remy, N. Pavese, and D. J. Brooks A Technique for Standardized Central Analysis of 6-18F-Fluoro-L-DOPA PET Data from a Multicenter Study J. Nucl. Med., July 1, 2004; 45(7): 1135 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. O'Brien, S. Colloby, J. Fenwick, E. D. Williams, M. Firbank, D. Burn, D. Aarsland, and I. G. McKeith Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies Arch Neurol, June 1, 2004; 61(6): 919 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain, March 1, 2004; 127(3): 550 - 560. [Abstract] [Full Text] [PDF] |
||||





